BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31966764)

  • 1. Relationships between clinicopathological prognostic factors in papillary thyroid microcarcinoma: a refined analysis based on 428 cases.
    Ciobanu Apostol D; Giuşcă SE; Căruntu ID; Lozneanu L; Andriescu EC; Moscalu M
    Int J Clin Exp Pathol; 2017; 10(8):8944-8956. PubMed ID: 31966764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
    Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
    Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
    J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.
    Lu ZZ; Zhang Y; Wei SF; Li DS; Zhu QH; Sun SJ; Li M; Li LI
    Mol Clin Oncol; 2015 May; 3(3):672-676. PubMed ID: 26137285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
    Kim WY; Kim HY; Son GS; Bae JW; Lee JB
    J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
    Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
    Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound assessment of degrees of extrathyroidal extension in papillary thyroid microcarcinoma.
    Moon SJ; Kim DW; Kim SJ; Ha TK; Park HK; Jung SJ
    Endocr Pract; 2014 Oct; 20(10):1037-43. PubMed ID: 24793922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Characteristics of Thyroid Microcarcinoma: Findings from a Hospital-Based Study in Vietnam.
    Nguyen BQ; Vu HT; Nguyen LMT; Nguyen QH; Paragomi P; Luu HN
    Discov Med; 2024 Jan; 36(180):209-216. PubMed ID: 38273761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
    Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
    Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients].
    Li XJ; Yang L; Ma BL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):52-57. PubMed ID: 29774686
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
    Zhang X; Zhang L; Xue S; Wang P; Chen G
    Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy.
    Karatzas T; Vasileiadis I; Charitoudis G; Karakostas E; Tseleni-Balafouta S; Kouraklis G
    Hormones (Athens); 2013; 12(4):529-36. PubMed ID: 24457401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
    Wang ZH; Zhang YJ; Fu GM; Chen YB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
    [No Abstract]   [Full Text] [Related]  

  • 17. Gray-scale ultrasonography combined with elastography imaging for the evaluation of papillary thyroid microcarcinoma: as a prognostic clinicopathology factor.
    Jin ZQ; Lin MY; Hu WH; Li WY; Bai SJ
    Ultrasound Med Biol; 2014 Aug; 40(8):1769-77. PubMed ID: 24768485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
    Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
    J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
    Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
    Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.